GF Fund Management
PYXS icon

GF Fund Management’s Pyxis Oncology PYXS Stock Holding History

GF Fund Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.11K Buy
1,334
+108
+9% +$327 ﹤0.01% 589
2026
Q2 		$3.69K Sell
1,226
-90
-7% -$172 ﹤0.01% 582
2026
Q1 		$1.92K Buy
1,316
+39
+3% +$59 ﹤0.01% 621
2025
Q4 		$1.47K Sell
1,277
-57
-4% -$201 ﹤0.01% 642
2025
Q3 		$2.96K Sell
1,334
-95
-7% -$137 ﹤0.01% 620
2025
Q2 		$1.57K Hold
1,429
– – ﹤0.01% 652
2025
Q1 		$1.4K Buy
1,429
+180
+14% +$240 ﹤0.01% 657
2024
Q4 		$1.95K Buy
+1,249
New +$3.6K ﹤0.01% 636

Other funds holding PYXS

Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
J. Derek Lewis & Associates
J. Derek Lewis & Associates Newport Beach, California $555M AUM 11.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $159M AUM 18.68% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

GF Fund Management's PYXS Position: Q3 2026 in Review

GF Fund Management increased its Pyxis Oncology (PYXS) stake by 8.8% in Q3 2026, buying an estimated $327 and bringing the position to 1,334 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

GF Fund Management first reported a position in PYXS in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.69K in Q2 2026. 21 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • GF Fund Management held 1,334 shares of Pyxis Oncology worth $3.11K as of Q3 2026.
  • GF Fund Management bought 108 Pyxis Oncology shares in Q3 2026, an estimated $327.
  • Pyxis Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #589 holding.
  • GF Fund Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 8 quarters since.
  • GF Fund Management's Pyxis Oncology position peaked at $3.69K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.